Non-EBV infection-associated hemophagocytic lymphohistiocytosis: a distinct subgroup where pathogen-directed therapy is essential and favorable outcomes are expected

References

• La Rosée P, Horne A, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133(23):2465–2477.
   PubMed Web of Science ®Google Scholar
• Scott RB, Robb-Smith AH. Histiocytic medullary reticulocytosis. Lancet. 1939;234(6047):194–198.
   Google Scholar
• de Saint Basile G, Fischer A. Defective cytotoxic granule-mediated cell death pathway impairs T lymphocyte homeostasis. Curr Opin Rheumatol. 2003;15(4):436–445.
   PubMed Web of Science ®Google Scholar
• Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286(5446):1957–1959.
   PubMed Web of Science ®Google Scholar
• Schram AM, Berliner N. How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood. 2015;125(19):2908–2914.
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, Brito-Zeró N P, Ló Pez-Guillermo A, et al. Adult haemophagocytic syndrome. Lancet. 2014;383(9927):1503–1516.
   PubMed Web of Science ®Google Scholar
• Janka GE, Lehmberg K. Hemophagocytic syndromes-an update. Blood Rev. 2014;28(4):135–142.
   PubMed Web of Science ®Google Scholar
• Janka GE, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program. 2013;2013:605–611.
   PubMedGoogle Scholar
• Trottestam H, Horne A, Aricò M, for the Histiocyte Society, et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood. 2011;118(17):4577–4584.
   PubMed Web of Science ®Google Scholar
• Wang Y, Huang W, Hu L, et al. Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis. Blood. 2015;126(19):2186–2192.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang Y, Wu L, et al. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Hematol Oncol. 2016;9(1):84.
   PubMedGoogle Scholar
• Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–131.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang Y, Wu L, et al. Application of an improved flow cytometry‑based NK cell activity assay in adult hemophagocytic lymphohistiocytosis. Int J Hematol. 2017;105(6):828–834.
   PubMed Web of Science ®Google Scholar
• Ehl S, Astigarraga I, von Bahr Greenwood T, et al. Recommendations for the use of etoposide-based therapy and bone marrow transplantation for the treatment of HLH: consensus statements by the HLH Steering Committee of the Histiocyte Society. J Allergy Clin Immunol Pract. 2018;6(5):1508–1517.
   PubMed Web of Science ®Google Scholar
• Brisse E, Wouters CH, Matthys P. Hemophagocytic lymphohistiocytosis (HLH): a heterogeneous spectrum of cytokine-driven immune disorders. Cytokine Growth Factor Rev. 2015;26(3):263–280.
   PubMed Web of Science ®Google Scholar
• Ishii E, Ohga S, Imashuku S, et al. Nationwide Survey of Hemophagocytic Lymphohistiocytosis in Japan. Int J Hematol. 2007;86(1):58–65.
   PubMed Web of Science ®Google Scholar
• Pei R, Wang Z, Wang Y, et al. A multicenter retrospective etiological analysis of 601 patients with hemophagocytic lymphohistiocytosis in China. Zhonghua Nei Ke Za Zhi. 2015;54:1018–1022.
   PubMedGoogle Scholar
• Brastianos PK, Swanson JW, Torbenson M, et al. Tuberculosis-associated haemophagocytic syndrome. Lancet Infect Dis. 2006;6(7):447–454.
   PubMed Web of Science ®Google Scholar
• Nair V, Das S, Sharma A, et al. A clinicopathological analysis of 26 patients with infection-associated haemophagocytic lymphohistiocytosis and the importance of bone marrow phagocytosis for the early initiation of immunomodulatory treatment. Postgrad Med J. 2013;89(1050):185–192.
   PubMed Web of Science ®Google Scholar
• Giri PP, Pal P, Ghosh A, Sinha R. Infection-associated haemophagocytic lymphohistiocytosis: a case series using steroids only protocol for management. Rheumatol Int. 2013;33(5):1363–1366.
   PubMed Web of Science ®Google Scholar
• Madkaikar M, Shabrish S, Desai M. Current Updates on Classification, Diagnosis and Treatment of Hemophagocytic Lymphohistiocytosis (HLH). Indian J Pediatr. 2016;83(5):434–443.
   PubMed Web of Science ®Google Scholar
• An Q, Fang DH, Xuan CM, et al. Lymphocyte subsets in children with hemophagocytic lymphohistiocytosis (HLH) and its clinical significance. Eur Rev Med Pharmacol Sci. 2018;22(7):2000–2004.
   PubMed Web of Science ®Google Scholar
• An Q, Wang Y, Hu S, et al. Clinical significance of lymphocyte subset changes in hemophagocytic lymphohistiocytosis of children. Exp Ther Med. 2016;12(6):3549–3552.
   PubMed Web of Science ®Google Scholar
• Dalal BI, Vakil AP, Khare NS, et al. Abnormalities of the lymphocyte subsets and their immunophenotype, and their prognostic significance in adult patients with hemophagocytic lymphohistiocytosis. Ann Hematol. 2015;94(7):1111–1117.
   PubMed Web of Science ®Google Scholar
• Shiota Y, Sato T, Ono T. Serum levels of soluble CD25 (soluble interleukin 2 receptor) in asthmatic patients. Arerugi. 1993;42:914–919.
   PubMedGoogle Scholar
• Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematol Am Soc Hematol Educ Program. 2009;2009(1):127–131.
   Google Scholar
• Jiang T, Ding X, Lu W. The prognostic significance of Beta2 microglobulin in patients with hemophagocytic lymphohistiocytosis. Dis Markers. 2016;2016:1–6.
   Web of Science ®Google Scholar
• Mazodier K, Marin V, Novick D, et al. Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. Blood. 2005;106(10):3483–3489.
   PubMed Web of Science ®Google Scholar
• Henter JI, Andersson B, Elinder G, et al. Elevated circulating levels of interleukin-1 receptor antagonist but not IL-1 agonists in hemophagocytic lymphohistiocytosis. Med Pediatr Oncol. 1996;27(1):21–25.
   PubMedGoogle Scholar
• Albeituni S, Verbist KC, Tedrick PE, et al. Mechanisms of action of ruxolitinib in murine odels of hemophagocytic lymphohis. Blood. 2019;134:147–159.
   Google Scholar